Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding

Journal of the American Veterinary Medical Association

Volumn 241, Issue 4, 2012, Pages 484-495

  Daniel Givens, M ^a   Marley, M Shonda D ^a   Jones, Craig A ^c,d   Ensley, Douglas T ^c,d   Galik, Patricia K ^a   Zhang, Yijing ^a   Riddell, Kay P ^a   Joiner, Kellye S ^a   Brodersen, Bruce W ^e   Rodning, Soren P ^b  

^a Department of Pathobiology   (United States)

^b and Veterinary Sciences   (United States)

^c AUBURN UNIVERSITY   (United States)

^d BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

^e UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE HERPES VIRUS; BOVINE VIRAL DIARRHEA; BREEDING; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS; MALE; METHODOLOGY; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; VETERINARY ABORTION; VIROLOGY;

ABORTION, VETERINARY; ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; BREEDING; CATTLE; DIARRHEA VIRUSES, BOVINE VIRAL; FEMALE; FETUS; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY RATE; VIRAL VACCINES;

ANIMALIA; BOS; BOVINE HERPESVIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 84864585175     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.241.4.484     Document Type: Article

References (30)

1. Grooms DL. Reproductive consequences of infection with bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 2004;20:5-19.
2. Muylkens B, Thiry J, Kirten P, et al. Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. Vet Res 2007;38:181-209.
3. Pena JG. U.S. cattle inventory down two percent; drought, high feed and energy costs and weak markets discourage re-building cycle. Ag-Eco News 2009;25.
4. Fairbanks KK, Rinehart CL, Ohnesorge WC, et al. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine. J Am Vet Med Assoc 2004;225:1898-1904.
5. Ficken MD, Ellsworth MA, Tucker CM. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study. Vet Ther 2006;7:283-294.
6. Ellsworth MA, Fairbanks KK, Behan S, et al. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams. Vet Ther 2006;7:295-304.
7. Ficken MD, Ellsworth MA, Tucker CM. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration- of-immunity study. Vet Ther 2006;7:275-282.
8. Zimmerman AD, Buterbaugh RE, Herbert JM, et al. Efficacy of bovine herpesvirus-1 inactivated vaccine against abortion and stillbirth in pregnant heifers. J Am Vet Med Assoc 2007;231:1386-1389.
9. Cravens RL, Ellsworth MA, Sorensen CD, et al. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers. J Am Vet Med Assoc 1996;208:2031-2034.
10. Ficken MD, Ellsworth MA, Fergen BJ. Separate challenge-ofimmunity studies establish fetal protection claims for IBR and BVD components of Bovi-Shield FP and PregGuard FP vaccine lines. Lincoln, Neb: Pfizer Inc, 2002.
11. Leyh RD, Fulton RW, Stegner JE, et al. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b. Am J Vet Res 2011;72:367-375.
12. Grooms DL, Bolin SR, Coe PH, et al. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle. Am J Vet Res 2007;68:1417-1422.
13. Walz PH, Givens MD, Cochran A, et al. Effect of dexamethasone administration on bulls with a localized testicular infection with bovine viral diarrhea virus. Can J Vet Res 2008;72:56-62.
14. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hygiene 1938;27:493-497.
15. Afshar A, Dulac GC, Dubuc C, et al. Comparative evaluation of the fluorescent antibody test and microtiter immunoperoxidase assay for detection of bovine viral diarrhea virus from bull semen. Can J Vet Res 1991;55:91-93.
16. Givens MD, Heath AM, Brock KV, et al. Detection of bovine viral diarrhea virus in semen obtained after inoculation of seronegative postpubertal bulls. Am J Vet Res 2003;64:428-434.
17. Givens MD, Galik PK, Riddell KP, et al. Replication and persistence of different strains of bovine viral diarrhea virus in an in vitro embryo production system. Theriogenology 2000;54:1093-1107.
18. Marley MSD, Givens MD, Galik PK, et al. Efficacy of recombinant trypsin against bovine herpesvirus-1 associated with in vitro-derived bovine embryos. Reprod Fert 2007;19:234-235.
19. Alabama weekly livestock summary Friday, May 21, 2010. Alabama Livestock Market News 2010;20(20).
20. Rodning SP, Marley MS, Zhang Y, et al. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus. Theriogenology 2010;73:1154-1163.
21. Kovacs F, Magyar T, Rinehart C, et al. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection. Vet Microbiol 2003;96:117-131.
22. Patel JR, Shilleto RW, Williams J, et al. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination. Arch Virol 2002;147:2453-2463.
23. Fulton RW, Ridpath JF, Ore S, et al. Bovine viral diarrhoea virus (BVDV) subgenotypes in diagnostic laboratory accessions: distribution of BVDV1a, 1b, and 2a subgenotypes. Vet Microbiol 2005;111:35-40.
24. Frey HR, Eicken K, Grummer B, et al. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. J Vet Med 2002;49:489-493.
25. Smith MW, Miller RB, Svoboda I, et al. Efficacy of an intranasal infectious bovine rhinotracheitis vaccine for the prevention of abortion in cattle. Can Vet J 1978;19:63-71.
26. Rokos K, Wang H, Seeger J, et al. Transport of viruses through fetal membranes: an in vitro model of perinatal transmission. J Med Virol 1998;54:313-319.
27. Rodger SM, Murray J, Underwood C, et al. Microscopical lesions and antigen distribution in bovine fetal tissues and placentae following experimental infection with bovine herpesvirus- 1 during pregnancy. J Comp Pathol 2007;137:94-101.
28. Fredriksen B, Press CM, Loken T, et al. Distribution of viral antigen in uterus, placenta and foetus of cattle persistently infected with bovine virus diarrhoea virus. Vet Microbiol 1999;64:109-122.
29. Swasdipan S, McGowan M, Phillips N, et al. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection. Microb Pathog 2002;32:49-60.
30. Taylor LF, Janzen ED, Ellis JA, et al. Performance, survival, necropsy, and virological findings from calves persistently infected with the bovine viral diarrhea virus originating from a single Saskatchewan beef herd. Can Vet J 1997;38:29-37.